शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ORIENTCERNSEORIENT CERATECH LIMITED· Industrial ProductsHighNeutral
Announced Mon, 10 Nov, 2025 · 20:32 IST

Q2 FY26 results: revenue up 59% YoY, PAT up 248%; new plant approved

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

ORIENTCER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+10.1%Reaction day
₹35.70
prior close
₹41.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+10.3% vs market
Electrodes & Refractories peers, median of 10sector-0.2%+10.3% vs sector

On the reaction day the stock moved 10.3 pts more than Nifty Microcap 250 and 10.3 pts more than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.8
10m
-6.1
15m
-4.3
30m
-4.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+10.1-0.3+10.3-0.2+10.3
Next day
+7.4+0.7+6.8+0.7+6.7
2d
+6.4+0.6+5.9+0.7+5.8
3d
+7.0+0.5+6.5+1.1+5.9
4d
+13.7+1.1+12.6+0.7+13.0
5d
+18.8+0.3+18.5+0.1+18.7
1w
+14.9-0.2+15.1+0.4+14.5
15d
+26.9-2.2+29.2+0.0+26.9
1m
+18.5-4.9+23.4-2.5+21.0
2m
+28.7-7.5+36.2-5.3+34.0
3m
+21.4-4.8+26.1+1.0+20.4
UpDownMarket · Nifty Microcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orient Ceratech reported Q2 FY26 standalone revenue of Rs 115.51 cr (up 59% YoY) and net profit of Rs 6.10 cr (up 248% YoY). H1 revenue was Rs 215.64 cr (up 25%) with PAT of Rs 9.22 cr (up 112%). Board approved a new foundry and resin coating plant at Baraya via subsidiary OAMPL, expected by end of Q4 FY26. New independent director appointed and MD Manan Shah re-appointed for 5 years. Auditor gave an unmodified review opinion.

Likely market impact

Strong revenue and profit growth year-on-year; expansion through new subsidiary plant signals confidence. Director changes are routine.